LFST Stock Up 45% after 5-Day Win Streak
LifeStance Health (LFST) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 45% return. The company has gained about $891 Mil in value over the last 5 days, with its current market capitalization at about $2.0 Bil. The stock remains 24.3% below its value at the end of 2024. This compares with year-to-date returns of 10% for the S&P 500.
LFST provides outpatient mental health services for all ages, treating conditions such as anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and PTSD. After this rally, is LFST still a buy – or is it time to lock in gains? Deep dive with Buy or Sell LFST.
Comparing LFST Stock Returns With The S&P 500
The following table summarizes the return for LFST stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | LFST | S&P 500 |
|---|---|---|
| 1D | 7.9% | 0.0% |
| 5D (Current Streak) | 44.6% | 2.0% |
| 1M (21D) | 26.8% | 3.3% |
| 3M (63D) | -2.8% | 9.8% |
| YTD 2025 | -24.3% | 10.0% |
| 2024 | -5.9% | 23.3% |
| 2023 | 58.5% | 24.2% |
| 2022 | -48.1% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has LFST behaved after prior drops? See LFST Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 87 S&P constituents with 3 days or more of consecutive gains and 15 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 61 | 9 |
| 4D | 6 | 1 |
| 5D | 11 | 4 |
| 6D | 7 | 1 |
| 7D or more | 2 | 0 |
| Total >=3 D | 87 | 15 |
Key Financials for LifeStance Health (LFST)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $1.1 Bil | $1.3 Bil |
| Operating Income | $-189.1 Mil | $-31.6 Mil |
| Net Income | $-186.3 Mil | $-57.4 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $333.0 Mil | $345.3 Mil |
| Operating Income | $1.6 Mil | $-2.9 Mil |
| Net Income | $0.7 Mil | $-3.8 Mil |
While LFST stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.